消化在线: Dr. Stephen Hanaue
来源：
Dr. Stephen Hanauer is a world leader in the treatment of inflammatory bowel diseases (IBD).He is the past chair of the Immunology, Microbiology and Inflammatory Bowel Disease Section of the American Gastroenterological Association (AGA). Dr. Hanauer is the recipient of the AGA's Fiterman Award for Clinical Research.He previously served as a member and chair of the Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee and currently chairs the International Organization for Inflammatory Bowel Disease.Dr. Hanauer is a member of the Crohn's and Colitis Foundation of America's National Scientific Advisory Committee.
Stephen B. Hanauer, MD, a distinguished physician-scientist and international leader in the treatment of inflammatory bowel disease, is joining Northwestern University Feinberg School of Medicine on January 1, 2014, as the Clifford Joseph Barborka Professor of Medicine and the medical director of the Digestive Disease Center.
Hanauer most recently served as the Joseph B. Kirsner Professor of Medicine, professor of clinical pharmacology, and chief of gastroenterology and nutrition at University of Chicago Pritzker School of Medicine. He also served as director of the Logan Center for Gastrointestinal Clinical Research and co-director of the Inflammatory Bowel Disease Research Center at Pritzker.
After earning his medical degree with honors from the University of Illinois in Chicago, Hanauer completed his internship and residency in internal medicine, in addition to his fellowship in gastroenterology, at the University of Chicago.
He currently serves as chair of the International Organization for Inflammatory Bowel Disease, secretary-elect of the American College of Gastroenterology, and is a member of the GI Specialty Board of Internal Medicine, the American College of Physicians, and American Gastroenterology Association. He previously served as chair of the Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee, where he authored the FDA's “Guidelines for Clinical Evaluation of Drugs for Patients with Inflammatory Bowel Disease.”
Hanauer has authored or co-authored hundreds of peer-reviewed journal articles, books, book chapters, monographs, and editorials. He also serves on the editorial boards of numerous medical journals, including the American Journal of Gastroenterology, Inflammatory Bowel Diseases, and the American Journal of Medicine, and designed and maintains the 6,000 patient Inflammatory Bowel Disease Registry.